BioSpace News Archive

Pharm Country

Electrocore Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced its plans to hold its fiscal year 2022 annual meeting of stockholders on Friday, December 2, 2022.

September 20, 2022
·
6 min read
BioMidwest

MIMEDX Announces Launch of AXIOFILL™

MiMedx Group, Inc., a transformational placental biologics company, announced the launch of AXIOFILL™, an Extracellular Matrix Particulate product derived from human placental tissue.

September 20, 2022
·
4 min read
Drug Development

Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine

Moat Biotechnology Corporation announces promising initial Phase I trial results of an intranasal COVID-19 vaccine, and kicks off an initial round of funding with lead investor Cortado Ventures.

September 20, 2022
·
5 min read
Business

Purigen Biosystems Signs Exclusive Agreement with Bucher Biotec AG to Strengthen Commercial Presence in the European Union

Purigen Biosystems, Inc. today announced a new distribution agreement with Bucher Biotec AG.

September 20, 2022
·
3 min read
Drug Development

Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects

Immunic, Inc. announced positive unblinded safety, tolerability and pharmacokinetic results from Part A and Part B of its phase 1 clinical trial of IMU-856 in healthy human subjects.

September 20, 2022
·
10 min read
Biotech Bay

Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area

Johnson & Johnson opened its San Francisco Bay Campus, a state-of-the-art Research & Development facility in the Bay Area, one of the world’s most established global hubs for innovation and entrepreneurship.

September 20, 2022
·
8 min read
Genetown

SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022

SOPHiA GENETICS, a cloud-native software company in the healthcare space, will host its first-ever Investor Day in-person at PUBLIC Hotel in New York City.

September 20, 2022
·
3 min read
Genetown

Arch Therapeutics Accepted to Present AC5® Advanced Wound System During Innovation Spotlight at 2022 Symposium on Advanced Wound Care (SAWC)

Arch Therapeutics, Inc., a marketer and developer of novel self-assembling wound care and biosurgical products, announced that AC5® Advanced Wound System was selected for the “Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care” session at the 2022 Symposium on Advanced Wound Care.

September 20, 2022
·
5 min read
Business

Current Biologics names chief executive

The board of Current Biologics has selected Tom Hochuli as chief executive officer of the startup company, which is focused on providing cell and gene therapy manufacturing and development services to the biotechnology and pharmaceutical industries.

September 20, 2022
·
3 min read
FDA

Zimmer Biomet Receives FDA Clearance for Identity™ Shoulder System for Shoulder Replacement

Zimmer Biomet Holdings, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Identity™ Shoulder System for anatomic, reverse and revision shoulder replacement.

September 20, 2022
·
5 min read